For more than two decades, colorectal cancer was one of the quiet success stories of American medicine, with diagnosis rates falling year after year as screening caught more tumors and precancerous growths early. That run has now ended. New national data show the overall rate rose in 2023 for the first time in more than 20 years.
Read next on Morning Overview: Arizona’s governor declared a statewide emergency after Flagstaff logged its wettest Nov. 1 on record
The increase is no longer confined to younger adults, where doctors first noticed it. It now reaches nearly every age group under 70, including older Americans who have long benefited most from screening, and the researchers behind the analysis say they cannot yet explain what is driving it.
From 55.2 to 36.7, and then back up
The study, published in NEJM Evidence, was led by Caitlin Murphy, a professor of pediatrics and public health sciences at the University of Chicago, who examined National Cancer Institute incidence data from 2000 through 2023. As the university’s release summarized, the age-adjusted incidence rate fell from 55.2 cases per 100,000 people in 2000 to 36.7 in 2022, then rose to 38.3 in 2023.
“This is the first time that [researchers] have seen an increase in the overall rate since in more than 20 years,” Murphy said. The analysis found rates now rising in every age group through ages 65 to 69, according to UChicago Medicine.
The stakes are high. Colorectal cancer is the second leading cause of cancer deaths in the United States and the leading cause among adults younger than 50. The National Cancer Institute’s SEER program estimates 158,850 new cases and 55,230 deaths in 2026, about 8.8% of all cancer deaths.
Screening explains part of the rise, but not the older groups
The sharpest jump came in people ages 45 to 49, where incidence rose 12.76% a year from 2019 through 2023. Much of that has a clear cause: national guidelines lowered the recommended starting age for routine screening from 50 to 45, and the U.S. Preventive Services Task Force now recommends screening for adults aged 45 to 49 as well as those 50 to 75. More testing finds cancers that would otherwise have gone undetected. Screening, Murphy said, “is doing as [intended] — it’s catching cancer earlier.”
Screening cannot account for the rest. Rates are also rising among adults ages 65 to 69, and the long decline has stalled among those 70 to 74. About 80% of people in those age groups are already current with recommended testing, so a surge in new screening is not a likely explanation. The researchers say the pattern suggests additional, unidentified risk factors may be offsetting decades of progress.
The team also tested whether the COVID-19 pandemic distorted the numbers, since screening and diagnoses dropped in 2020 and 2021. The upward trend held even after those years were removed, and screening activity had largely recovered by January 2021, making pandemic disruption an unlikely explanation for the 2023 rise.
A birth cohort effect, with the cause still unknown
Murphy had expected the trend in younger adults to show up eventually in older people. She describes it as a “birth cohort effect”: people born in the 1960s and later appear to carry a higher risk of colorectal cancer that becomes visible as they reach middle age and beyond. She described a birth cohort effect as “the interaction of age and time,” adding that as people born around the same time age together, “more colorectal cancers [will be] diagnosed.”
The framework describes who is affected, not why. The study does not identify what changed for those generations, and the authors present the finding as a reason to search for causes rather than an answer. “These results motivate [researchers] to understand reasons for this rise, so risk factors can be identified and possibly reduced,” said Sonia Kupfer, director of the Gastrointestinal Cancer Risk and Prevention Clinic at UChicago Medicine.
Until the causes are known, screening remains the main tool. The Centers for Disease Control and Prevention notes that colorectal cancer almost always develops from abnormal growths called polyps, and that screening tests can find polyps so they can be removed before they turn into cancer, as well as catch cancer early when treatment works best. People with a family history or certain genetic syndromes, such as Lynch syndrome or familial adenomatous polyposis, may need to start earlier than 45 or be screened more often, and for adults between 76 and 85 the CDC says the decision should be made individually with a doctor.
The researchers warn that a sustained rise would add pressure on the health system, as more patients need treatment and long-term survivorship care. Whether 2023’s increase becomes a lasting trend will show up in the next years of National Cancer Institute data.
This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.
More from Morning Overview
- Over 20 trillion gallons of rain fell on the Four Corners states and Nevada in two weeks
- 11 engines built to run well past 200,000 miles
- Two Kentucky residents died when a small plane crashed at Missouri’s Lake of the Ozarks, and the NTSB is investigating
- A handful of car transmissions are so tough that mechanics say they almost never die